David Harrison Archives
Vanderbilt mourns loss of renowned clinical pharmacologist Jackson Roberts II, MD
Jun. 5, 2023—Jackson Roberts II, MD, an internationally known clinical pharmacologist in the Vanderbilt University School of Medicine who helped define the role of lipid peroxidation and oxidative stress in human disease, died May 31 in Nashville. He was 79.
Several from VUMC among most highly cited researchers
Nov. 17, 2022—Nine current faculty members of the Vanderbilt University School of Medicine have made this year’s list of scientists whose papers have been cited most frequently by other researchers.
A new mechanism for lupus
Aug. 30, 2022—Vanderbilt researchers describe a new mechanism for the most common form of lupus and suggest a new treatment approach to this autoimmune disease.
VUMC renewed as a Comprehensive Hypertension Center
Jun. 2, 2022—The Vanderbilt Comprehensive Hypertension Center has been awarded renewal of the American Heart Association’s Comprehensive Hypertension Center Certification,
Harrison awarded AHA Basic Research Prize for 2018
Nov. 15, 2018—David G. Harrison, MD, the Betty and Jack Bailey Professor of Cardiology and director of the Division of Clinical Pharmacology at Vanderbilt University School of Medicine, has been awarded the American Heart Association’s Basic Research Prize for 2018.
Stretch, inflammation and hypertension
Sep. 27, 2018—New research sheds light on how changes in blood vessel forces enhance immune cell activation and promote hypertension.
VU study explores inflammation, hypertension link
Feb. 12, 2015—The evidence is increasing: the immune system and inflammation are key contributors to high blood pressure.
Immune cells’ role in hypertension
Oct. 24, 2014—Vanderbilt researchers have discovered that certain immune cells contribute to the development of hypertension, suggesting novel targets for treating the disease.
AHA grant creates coalition to prevent heart disease, stroke
Jul. 10, 2014—Vanderbilt University Medical Center is one of four institutions that are part of a new research network aimed at preventing heart disease and stroke, the two leading causes of death in the world.
Clinical Pharmacology celebrates 50th anniversary
Jun. 13, 2013—Since it was founded in 1963, the Vanderbilt Division of Clinical Pharmacology has pioneered “translational science” and continues to transform medical practice worldwide, speakers at the division’s 50th anniversary scientific symposium said last week.
Record number elected AAAS fellows
Nov. 29, 2012—Seventeen members of Vanderbilt University’s faculty have been elected fellows of the American Association for the Advancement of Science (AAAS) this year.
VU hosts international vascular biology research meeting
Aug. 2, 2012—More than 100 students, faculty and scientists from around the world attended a four-day program on vascular biology research last week at Vanderbilt University.
